PAT-SM6 is manufactured in the USA.
Yes, getting approval to do trials in Germany is not easy...controlled by the Paul Ehrlich Institute. No reason why PAB can't get approval though as they have successfully navigated the approval process before and executed a successful clinical trial in Germany. Question is though...do they have the right people to get this done and if they are making progress, then why are we not hearing anything about it?????
What's the root cause of PAB's poor SP performance?, page-13
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 26519870 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7889760 | 12 |
View Market Depth
| Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |